A randomized trial of intravenous and oral iron in chronic kidney disease

Although iron is commonly used to correct iron deficiency anemia (IDA) in chronic kidney disease (CKD) its effect on kidney function is unclear. To assess this, we randomly assigned patients with Stage 3 and 4 CKD and IDA to either open-label oral ferrous sulfate (69 patients to 325 mg three times d...

Descripción completa

Detalles Bibliográficos
Autores principales: Agarwal, Rajiv, Kusek, John W., Pappas, Maria K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4589436/
https://www.ncbi.nlm.nih.gov/pubmed/26083656
http://dx.doi.org/10.1038/ki.2015.163

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4589436/
https://www.ncbi.nlm.nih.gov/pubmed/26083656
http://dx.doi.org/10.1038/ki.2015.163

Ejemplares similares